Plant-Based Med Shows Promise for Smoking Cessation
More than 20% of smokers who took cytisinicline remained smoke-free up to 3 months after treatment, results from the first large-scale US clinical trial of the drug show.
Stay updated with breaking news from Nancy Rigotti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than 20% of smokers who took cytisinicline remained smoke-free up to 3 months after treatment, results from the first large-scale US clinical trial of the drug show.
Improved rates of continuous abstinence after 6 or 12 weeks
The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and well tolerated in adults who wished to break their nicotine dependence.
Operator: Thank you. Good day, ladies and gentlemen, and welcome to the Achieve Life Sciences First Quarter 2023 Earnings Conference Call.
Many Americans use vapes to quit smoking cigarettes. But because of nicotine levels of e-cigarettes, patients also may need help quitting the unauthorized cessation tools.